Join free webinar!

ONLY LIMITED SPOTS

By submitting this form you agree to the privacy policy.

Genomics Drives the Next Move in Digital Healthcare

February 04 , 2022 - 2PM CET (KSA: 4PM – UAE: 5PM)

  • How genomic data can improve the understanding of diseases with the help of Artificial Intelligence, and how it leads to more accurate diagnosis and better treatment recommendations.
  • Why building big data sets for different diseases, especially rare diseases and cancer is crucial, and why the data sharing around the world is critical to advance precision medicine.
  • How Arcensus is playing a major role in setting industry standards for genomics and health data to improve interoperability in the genomics landscape worldwide.
  • How the company's global reach can serve as the foundation for the precise diagnosis, as well as provide the best health recommendations for each analysed individual.

Personalized medicine requires big data. The healthcare system, doctors, and pharmaceutical companies all need access to large amount of health data, especially genomic information covering different populations and a wide range of diseases, in order to better understand rare diseases and to improve the treatment of cancer patients.

During this Webinar, our Founder and CEO Prof. Dr. Arndt Rolfs, who is a German professor and one of the world's most renowned experts on genetic diseases with more than 30 years of experience and over 400 international scientific publications, will help you understand the following:

Arndt is a Professor at the University of Rostock, Germany. He is a multi-entrepreneur in biotech, founder, and former CEO of several innovative biotech companies, including Nasdaq-listed company CENTOGENE. 

He received his MD in 1985 and was granted a tenure track professorship for clinical neurology in 1997 at the University of Rostock. In 2008, Arndt was appointed Director of the Albrecht-Kossel-Institute for Neuroregeneration at the University of Rostock. Arndt has initiated multiple international multicenter studies in genetic disorders with an extensive track record in medical and scientific publications.

Speaker

Prof. Dr. Arndt Rolfs,
CEO and Founder Arcensus GmbH

Arndt is a Professor at the University of Rostock, Germany. He is a multi-entrepreneur in biotech, founder, and former CEO of several innovative biotech companies, including Nasdaq-listed company CENTOGENE. 

He received his MD in 1985 and was granted a tenure track professorship for clinical neurology in 1997 at the University of Rostock. In 2008, Arndt was appointed Director of the Albrecht-Kossel-Institute for Neuroregeneration at the University of Rostock. Arndt has initiated multiple international multicenter studies in genetic disorders with an extensive track record in medical and scientific publications.

Speaker

Prof. Dr. Arndt Rolfs,
CEO and Founder Arcensus GmbH

Genomics Drives the Next Move in 
Digital Healthcare

February 04, 2022 - 2PM CET 

2022. All rights reserved by arcensus GmbH

2022. All rights reserved by arcensus GmbH

Personalized medicine requires big data. The healthcare system, doctors, and pharmaceutical companies all need access to large amount of health data, especially genomic information covering different populations and a wide range of diseases, in order to better understand rare diseases and to improve the treatment of cancer patients.

During this Webinar, our Founder and CEO Prof. Dr. Arndt Rolfs, who is a German professor and one of the world's most renowned experts on genetic diseases with more than 30 years of experience and over 400 international scientific publications, will help you understand the following:

Duration: 45 minutes

(KSA: 4PM – UAE: 5PM) - Duration: 45 minutes